Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01151371 · ClinicalTrials.gov registry record · NA
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 452
- Enrollment target
- 20
- Study locations
NCT01151371: Completed NA study of Myopia, sponsored by Johnson & Johnson Vision Care.
NCT01151371 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 452 participants, above the 263-participant average among 90 other Myopia trials with a reported enrollment target (72% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01151371, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 452 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the study is to compare the clinical performance of silicone hydrogel daily disposable contact lenses, conventional hydrogel daily disposable contact lenses and silicone hydrogel monthly replacement contact lenses.
Primary Outcome
Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.
Conditions Studied
Interventions
- DEVICE narafilcon B contact lens
- DEVICE nelfilcon A contact lens
- DEVICE lotrafilcon B contact lens
Study Locations (20)
Florida
- - Jacksonville
- - Jacksonville
- - Tampa
- - Winter Park
California
- - Brea
- - Canoga Park
- - Corona
Missouri
- - Blue Springs
- - Independence
- - Lake Ozark
Ohio
- - Chagrin Falls
- - North Olmsted
- - Warren
Connecticut
- - Bridgeport
Georgia
- - Roswell
Indiana
- - Mishawaka
Massachusetts
- - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2010-02-01 |
| Est. Completion | 2010-04-01 |
| Phase | NA |
What the finished NCT01151371 record still lists
NCT01151371 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, above the 263-participant average among 90 other Myopia trials with a reported enrollment target (72% higher).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 3 interventions - of which narafilcon B contact lens is the first listed.
NCT01151371 names 20 study sites across 11 states, led by Florida, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT01151371 about?
NCT01151371 is a clinical study titled "Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens". The objective of the study is to compare the clinical performance of silicone hydrogel daily disposable contact lenses, conventional hydrogel daily disposable contact lenses and silicone hydrogel monthly replacement contact lenses.
What is the current status of trial NCT01151371?
This trial is currently completed. It is a NA study. The enrollment target is 452 participants. The study started on 2010-02-01. Estimated completion is 2010-04-01.
What conditions does trial NCT01151371 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01151371?
The interventions under investigation include: narafilcon B contact lens (DEVICE), nelfilcon A contact lens (DEVICE), lotrafilcon B contact lens (DEVICE).
Who is sponsoring clinical trial NCT01151371?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01151371 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01151371's enrollment target sits among peer trials
452 9th of 90 higher than 82 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI